Clinical Trial Update: Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of cutaneous LEO 39652 Cream in adults with Atopic Dermatitis and in healthy subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 39652 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED